These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23707259)

  • 1. The discovery of BMS-457, a potent and selective CCR1 antagonist.
    Gardner DS; Santella JB; Duncia JV; Carter PH; Dhar TG; Wu H; Guo W; Cavallaro C; Van Kirk K; Yarde M; Briceno SW; Grafstrom RR; Liu R; Patel SR; Tebben AJ; Camac D; Khan J; Watson A; Yang G; Rose A; Foster WR; Cvijic ME; Davies P; Hynes J
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3833-40. PubMed ID: 23707259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritis.
    Santella JB; Gardner DS; Duncia JV; Wu H; Dhar M; Cavallaro C; Tebben AJ; Carter PH; Barrish JC; Yarde M; Briceno SW; Cvijic ME; Grafstrom RR; Liu R; Patel SR; Watson AJ; Yang G; Rose AV; Vickery RD; Caceres-Cortes J; Caporuscio C; Camac DM; Khan JA; An Y; Foster WR; Davies P; Hynes J
    J Med Chem; 2014 Sep; 57(18):7550-64. PubMed ID: 25101488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel series of human CCR1 antagonists.
    Xie YF; Sircar I; Lake K; Komandla M; Ligsay K; Li J; Xu K; Parise J; Schneider L; Huang D; Liu J; Sakurai N; Barbosa M; Jack R
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2215-21. PubMed ID: 18329267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonists.
    Pennell AM; Aggen JB; Sen S; Chen W; Xu Y; Sullivan E; Li L; Greenman K; Charvat T; Hansen D; Dairaghi DJ; Wright JJ; Zhang P
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1228-31. PubMed ID: 23374868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and optimization of pyrazole amides as antagonists of CCR1.
    Harcken C; Sarko C; Mao C; Lord J; Raudenbush B; Razavi H; Liu P; Swinamer A; Disalvo D; Lee T; Lin S; Kukulka A; Grbic H; Patel M; Patel M; Fletcher K; Joseph D; White D; Amodeo L; Berg K; Brown M; Thomson DS
    Bioorg Med Chem Lett; 2019 Feb; 29(3):435-440. PubMed ID: 30455146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure activity relationships of fused bicyclic and urea derivatives of spirocyclic compounds as potent CCR1 antagonists.
    Hossain N; Mensonides-Harsema M; Cooper ME; Eriksson T; Ivanova S; Bergström L
    Bioorg Med Chem Lett; 2014 Jan; 24(1):108-12. PubMed ID: 24332486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel non-peptide CCR1 receptor antagonists.
    Ng HP; May K; Bauman JG; Ghannam A; Islam I; Liang M; Horuk R; Hesselgesser J; Snider RM; Perez HD; Morrissey MM
    J Med Chem; 1999 Nov; 42(22):4680-94. PubMed ID: 10579830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spirocyclic compounds, potent CCR1 antagonists.
    Hossain N; Ivanova S; Bergare J; Eriksson T
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1883-6. PubMed ID: 23414842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H₁ antagonists. Part I.
    Furber M; Alcaraz L; Luckhurst C; Bahl A; Beaton H; Bowers K; Collington J; Denton R; Donald D; Kinchin E; MacDonald C; Rigby A; Riley R; Soars M; Springthorpe B; Webborn P
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7702-6. PubMed ID: 23142617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and discovery of a novel CCR1 antagonist.
    Naya A; Sagara Y; Ohwaki K; Saeki T; Ichikawa D; Iwasawa Y; Noguchi K; Ohtake N
    J Med Chem; 2001 Apr; 44(9):1429-35. PubMed ID: 11311066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and structure activity relationships of spirocyclic compounds as potent CCR1 antagonists.
    Hossain N; Ivanova S; Bergare J; Mensonides-Harsema M; Cooper ME
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3500-4. PubMed ID: 23659855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and optimization of substituted piperidines as potent, selective, CNS-penetrant alpha4beta2 nicotinic acetylcholine receptor potentiators.
    Albrecht BK; Berry V; Boezio AA; Cao L; Clarkin K; Guo W; Harmange JC; Hierl M; Huang L; Janosky B; Knop J; Malmberg A; McDermott JS; Nguyen HQ; Springer SK; Waldon D; Woodin K; McDonough SI
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5209-12. PubMed ID: 18789861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and structure-activity relationships of zwitterionic spirocyclic compounds as potent CCR1 antagonists.
    Hossain N; Ivanova S; Timén ÅS; Bergare J; Mussie T; Bergström L
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4026-30. PubMed ID: 23769642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a piperidine-4-carboxamide CCR5 antagonist (TAK-220) with highly potent Anti-HIV-1 activity.
    Imamura S; Ichikawa T; Nishikawa Y; Kanzaki N; Takashima K; Niwa S; Iizawa Y; Baba M; Sugihara Y
    J Med Chem; 2006 May; 49(9):2784-93. PubMed ID: 16640339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists.
    Suzuki T; Moriya M; Sakamoto T; Suga T; Kishino H; Takahashi H; Ishikawa M; Nagai K; Imai Y; Sekino E; Ito M; Iwaasa H; Ishihara A; Tokita S; Kanatani A; Sato N; Fukami T
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3072-7. PubMed ID: 19403308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure function differences in nonpeptide CCR1 antagonists for human and mouse CCR1.
    Onuffer J; McCarrick MA; Dunning L; Liang M; Rosser M; Wei GP; Ng H; Horuk R
    J Immunol; 2003 Feb; 170(4):1910-6. PubMed ID: 12574358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a sulfonamide series of CCR2 antagonists.
    Peace S; Philp J; Brooks C; Piercy V; Moores K; Smethurst C; Watson S; Gaines S; Zippoli M; Mookherjee C; Ife R
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3961-4. PubMed ID: 20627722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and lead optimization of a novel series of CC chemokine receptor 1 (CCR1)-selective piperidine antagonists via parallel synthesis.
    Cavallaro CL; Briceno S; Chen J; Cvijic ME; Davies P; Hynes J; Liu RQ; Mandlekar S; Rose AV; Tebben AJ; Van Kirk K; Watson A; Wu H; Yang G; Carter PH
    J Med Chem; 2012 Nov; 55(22):9643-53. PubMed ID: 23075267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel pyrrolidine ureas as C-C chemokine receptor 1 (CCR1) antagonists.
    Merritt JR; Liu J; Quadros E; Morris ML; Liu R; Zhang R; Jacob B; Postelnek J; Hicks CM; Chen W; Kimble EF; Rogers WL; O'Brien L; White N; Desai H; Bansal S; King G; Ohlmeyer MJ; Appell KC; Webb ML
    J Med Chem; 2009 Mar; 52(5):1295-301. PubMed ID: 19183043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.
    Yang ZQ; Barrow JC; Shipe WD; Schlegel KA; Shu Y; Yang FV; Lindsley CW; Rittle KE; Bock MG; Hartman GD; Uebele VN; Nuss CE; Fox SV; Kraus RL; Doran SM; Connolly TM; Tang C; Ballard JE; Kuo Y; Adarayan ED; Prueksaritanont T; Zrada MM; Marino MJ; Graufelds VK; DiLella AG; Reynolds IJ; Vargas HM; Bunting PB; Woltmann RF; Magee MM; Koblan KS; Renger JJ
    J Med Chem; 2008 Oct; 51(20):6471-7. PubMed ID: 18817368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.